Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 1, 1997
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria
G Edan, D Miller, M Clanet, et al.
Neurology
|
September 22, 2010
Long-term follow-up of neuromyelitis optica with a pediatric onset
N Collongues, R Marignier, H Zéphir, et al.
Revue Neurologique
|
October 22, 2013
[Cavitary lesions in multiple sclerosis: multicenter study on twenty patients]
A Corlobé, D Renard, C Goizet, et al.
Multiple Sclerosis and Related Disorders
|
October 11, 2020
Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis
H-P Hartung, T Berger, R A Bermel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 18, 2011
High-risk syndrome for neuromyelitis optica: a descriptive and comparative study
N Collongues, R Marignier, H Zéphir, et al.
Neurology
|
August 24, 2005
Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data
J Sastre-Garriga, G T Ingle, M Rovaris, et al.
Journal of Neurology
|
May 2, 2015
Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study
A Siri, Clarisse Carra-Dalliere, X Ayrignac, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 13, 2015
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis
J Kuhle, M Hardmeier, G Disanto, et al.
European Journal of Neurology
|
July 31, 2013
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort
O Outteryck, J C Ongagna, B Brochet, et al.
Revue Neurologique
|
July 16, 2025
Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers
A Gaulier, V Touitou, M-B Rougier, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 1, 1997
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria
G Edan, D Miller, M Clanet, et al.
Neurology
|
September 22, 2010
Long-term follow-up of neuromyelitis optica with a pediatric onset
N Collongues, R Marignier, H Zéphir, et al.
Revue Neurologique
|
October 22, 2013
[Cavitary lesions in multiple sclerosis: multicenter study on twenty patients]
A Corlobé, D Renard, C Goizet, et al.
Multiple Sclerosis and Related Disorders
|
October 11, 2020
Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis
H-P Hartung, T Berger, R A Bermel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 18, 2011
High-risk syndrome for neuromyelitis optica: a descriptive and comparative study
N Collongues, R Marignier, H Zéphir, et al.
Neurology
|
August 24, 2005
Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data
J Sastre-Garriga, G T Ingle, M Rovaris, et al.
Journal of Neurology
|
May 2, 2015
Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study
A Siri, Clarisse Carra-Dalliere, X Ayrignac, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 13, 2015
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis
J Kuhle, M Hardmeier, G Disanto, et al.
European Journal of Neurology
|
July 31, 2013
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort
O Outteryck, J C Ongagna, B Brochet, et al.
Revue Neurologique
|
July 16, 2025
Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers
A Gaulier, V Touitou, M-B Rougier, et al.
Page
of 9